Skip to main content

Spirometer Market Size Expected to Reach USD 789.0 Million by 2028, With 5.2% CAGR

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global spirometer market size is projected to reach USD 789.0 million in 2028, at a CAGR of 5.2% during the forecast period, 2021-2028

Pune, India, March 08, 2023 (GLOBE NEWSWIRE) — The global spirometer market size was USD 528.6 million in 2020 and is projected to grow from USD 554.5 million in 2021 to USD 789.0 million by 2028, exhibiting a CAGR of 5.2% during the 2021-2028 period. The rising cases of respiratory disorders will have an excellent effect on the spirometer market growth in the forthcoming years, states Fortune Business Insights, in a report, titled “Spirometer Market, 2021-2028.”

Notable Development:

AireHealth Inc. announced a strategic merger with BreathResearch. This joint venture will concentrate on the creation of a virtual care platform for respiratory illnesses.

ERT announced the launch of ERT iSpiro Virtual Visits, which enables real-time coaching during at-home pulmonary function tests (PFT). With iSpiro Virtual Visits, ERT delivers on its commitment to offer customer and patient-oriented innovations that enable decentralization.


Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spirometers-market-100486


Report Scope

Report CoverageDetails
Forecast Period2021 to 2028
Forecast Period 2021 to 2028 CAGR5.2%
2028 Value ProjectionUSD 789.0 Million
Base Year2020
Market Size in 2021USD 554.5 Million
Historical Data2017 to 2019
No. of Pages139


Key Takeaways:

  • Growing demand for accurate devices for lung function assessment, the major players are focusing on investments to develop advanced devices.
  • The market size in North America stood at USD 265.0 million in 2020.
  • The devices segment is expected to be the leading segment in this market during the forecast period.
  • Constant innovations are one of the growth factors responsible for driving the market.


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486



Driving Factor:

Increasing Prevalence of COPD to Drive Market

COPD is the world’s third-biggest cause of death, putting a major strain on patients and healthcare systems. In the U.S., it is among the largest causes of death, impacting around 16 million people, according to the National Heart, Lung, and Blood Institute. Tobacco smoking is a key risk factor for COPD. Other environmental exposures, such as air pollution and biomass fuel exposure, may, nevertheless, have serious health consequences. The rising prevalence of the condition is a worrying trend that will fuel demand for diagnostic devices over the projection period. Thus, boosting the growth of the spirometer market.

Market Segments:

Based on product type, the market is classified into devices, software, and accessories & consumables.   
Because of the introduction of advanced software solutions for testing procedures, the software segment is expected to increase significantly.

Volume measurement and peak flow meters are two types of meters available in the market. In the year 2020, volume measurement devices dominated the market. The device’s dominance can be attributed to its ability to produce precise results while being simple to use.
The market is divided into three categories based on application: chronic obstructive pulmonary disease (COPD), asthma, and others. Hospitals, diagnostic centers, home care settings, physician/primary care offices, and clinics are the end-user segments of the market.

By Product Type

  • Devices
  • Software
  • Consumables & Accessories

By Type

  • Volume Measurement
  • Peak Flow Meters

By Application

  • COPD
  • Asthma
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Physician/Primary Care Offices or Clinics
  • Other Facilities

By Geography

  • North America (By Product Type, By Type, By Application, By End-User, By Country)
  • Europe (By Product Type, By Type, By Application, By End-User, By Country)
  • Asia Pacific (By Product Type, By Type, By Application, By End User, By Country)
  • Latin America (By Product Type, By Type, By Application, By End User, By Country)
  • Middle East & Africa (By Product Type, By Type, By Application, By End User, By Country)


Quick Buy – Spirometer Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100486


Regional Insights:

Rising Incidence of Asthma to Promote Growth in North America

In 2020, the North American market stood at USD 265.0 million and will capture substantial percentage of spirometer market share by 2028. The rising prevalence of chronic obstructive pulmonary disease, asthma, and other respiratory disorders has contributed to this region’s domination. This has put a greater financial strain on the healthcare system, prompting the development of precision equipment to address the problem. The respiratory disease COPD, for example, is the fourth biggest cause of mortality, according to the Global Initiative for Chronic Obstructive Lung Disease (COPD) 2020 study, and the disease is putting a great strain on healthcare systems to lower its prevalence.

Major Companies Focus on Distribution Network to Strengthen Position

Because of the varied product portfolio and impressive distribution network of big corporations in developed and emerging nations, the market is consolidated. Companies such as ndd Medizintechnik AG and COSMED srl, among others, have recently released market-leading products.

The Report Lists the Key Companies Profiled in the Market Report:

  • ndd Medizintechnik AG (Zurich, Switzerland)
  • COSMED srl (Rome, Italy)
  • MGC Diagnostics Corporation (Minnesota, U.S)
  • Morgan Scientific (Massachusetts, U.S)
  • Chest M.I., Inc. (Tokyo, Japan)
  • VYAIRE (Illinois, U.S)
  • Ganshorn Medizin Electronic GmbH (Niederlauer, Germany)
  • Medical International Research (MIR) (Rome, Italy)
  • Other Players

FAQs

How big is the spirometer market?

Sspirometer Market size was USD 554.5 million in 2021. It is expected to reach USD 789.0 million by 2028.

Who are the key players in the spirometer market?

Some of the key market players in the spirometer market include are ndd Medizintechnik AG, COSMED srl, MGC Diagnostics Corporation, Morgan Scientific, Chest M.I., Inc., VYAIRE, Ganshorn Medizin Electronic GmbH, Medical International Research


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/spirometers-market-100486


Related Reports:

Pulmonary Function Testing System Market Size, Share, Revenue Forecast and Opportunities

Respiratory Devices Market Size, Share, Growth & Industry Analysis

Chronic Obstructive Pulmonary Disease Drugs Market Overview, Industry Share and Forecast

Exam Room Equipment Market Size, Share, Opportunities & Analysis

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.